Published in Mol Cancer on November 19, 2014
MiR-940 inhibits hepatocellular carcinoma growth and correlates with prognosis of hepatocellular carcinoma patients. Cancer Sci (2015) 0.93
MicroRNA-940 promotes tumor cell invasion and metastasis by downregulating ZNF24 in gastric cancer. Oncotarget (2015) 0.89
MiR-940 Inhibited Cell Growth and Migration in Triple-Negative Breast Cancer. Med Sci Monit (2016) 0.77
miR-940 Suppresses Tumor Cell Invasion and Migration via Regulation of CXCR2 in Hepatocellular Carcinoma. Biomed Res Int (2016) 0.77
MIEN1 promotes oral cancer progression and implicates poor overall survival. Cancer Biol Ther (2015) 0.77
Microarray expression profile of circular RNAs in chronic thromboembolic pulmonary hypertension. Medicine (Baltimore) (2017) 0.76
MIEN1 is tightly regulated by SINE Alu methylation in its promoter. Oncotarget (2016) 0.76
Proteome Profiling of Urinary Exosomes Identifies Alpha 1-Antitrypsin and H2B1K as Diagnostic and Prognostic Biomarkers for Urothelial Carcinoma. Sci Rep (2016) 0.75
Exosomal miR-940 maintains SRC-mediated oncogenic activity in cancer cells: a possible role for exosomal disposal of tumor suppressor miRNAs. Oncotarget (2017) 0.75
Identification and functional characterization of the miRNA-gene regulatory network in chronic myeloid leukemia lineage negative cells. Sci Rep (2016) 0.75
MiR-30b Attenuates Neuropathic Pain by Regulating Voltage-Gated Sodium Channel Nav1.3 in Rats. Front Mol Neurosci (2017) 0.75
Hallmarks of cancer: the next generation. Cell (2011) 140.01
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc (2009) 137.99
Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell (2005) 96.87
Cancer statistics, 2013. CA Cancer J Clin (2013) 84.72
NIH Image to ImageJ: 25 years of image analysis. Nat Methods (2012) 84.41
Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res (2008) 54.83
Combinatorial microRNA target predictions. Nat Genet (2005) 50.48
MicroRNA signatures in human cancers. Nat Rev Cancer (2006) 46.29
miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res (2006) 39.25
Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A (2008) 33.65
The microRNA.org resource: targets and expression. Nucleic Acids Res (2007) 16.26
Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev (2006) 15.20
Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem (2010) 12.06
Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol (2009) 11.50
microRNAs as oncogenes and tumor suppressors. Dev Biol (2006) 10.68
A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell (2011) 10.50
Tumor metastasis: molecular insights and evolving paradigms. Cell (2011) 10.34
Enhancements and modifications of primer design program Primer3. Bioinformatics (2007) 10.15
Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol (2014) 10.04
EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene (2010) 9.66
miRWalk--database: prediction of possible miRNA binding sites by "walking" the genes of three genomes. J Biomed Inform (2011) 8.50
The Snail genes as inducers of cell movement and survival: implications in development and cancer. Development (2005) 8.42
MicroRNA expression profiling in prostate cancer. Cancer Res (2007) 8.04
Widespread deregulation of microRNA expression in human prostate cancer. Oncogene (2007) 5.70
MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol Med (2012) 5.46
The multilayered complexity of ceRNA crosstalk and competition. Nature (2014) 4.15
Epithelial-mesenchymal plasticity in carcinoma metastasis. Genes Dev (2013) 3.63
Targeting protein prenylation for cancer therapy. Nat Rev Cancer (2011) 2.60
DIANA-microT web server v5.0: service integration into miRNA functional analysis workflows. Nucleic Acids Res (2013) 2.32
Predicting degree of benefit from adjuvant trastuzumab in NSABP trial B-31. J Natl Cancer Inst (2013) 2.28
Micromarkers: miRNAs in cancer diagnosis and prognosis. Expert Rev Mol Diagn (2010) 2.00
Overcoming anoikis--pathways to anchorage-independent growth in cancer. J Cell Sci (2011) 1.86
MicroRNAs and prostate cancer. Endocr Relat Cancer (2010) 1.63
High-resolution genomic and expression analyses of copy number alterations in HER2-amplified breast cancer. Breast Cancer Res (2010) 1.62
Epithelial-to-mesenchymal transition in prostate cancer: paradigm or puzzle? Nat Rev Urol (2011) 1.53
MicroRNA let-7c suppresses androgen receptor expression and activity via regulation of Myc expression in prostate cancer cells. J Biol Chem (2011) 1.52
Novel diagnostic biomarkers for prostate cancer. J Cancer (2010) 1.36
Circulating microRNAs as potential new biomarkers for prostate cancer. Br J Cancer (2013) 1.21
Identification of microRNA-98 as a therapeutic target inhibiting prostate cancer growth and a biomarker induced by vitamin D. J Biol Chem (2012) 1.16
Elevated expression of prostate cancer-associated genes is linked to down-regulation of microRNAs. BMC Cancer (2014) 1.12
A gene on the HER2 amplicon, C35, is an oncogene in breast cancer whose actions are prevented by inhibition of Syk. Br J Cancer (2010) 1.09
C35 (C17orf37) is a novel tumor biomarker abundantly expressed in breast cancer. Mol Cancer Ther (2006) 1.05
Novel gene C17orf37 in 17q12 amplicon promotes migration and invasion of prostate cancer cells. Oncogene (2009) 0.97
Epithelial-mesenchymal transition: focus on metastatic cascade, alternative splicing, non-coding RNAs and modulating compounds. Mol Cancer (2013) 0.96
β-Catenin signaling in hepatocellular cancer: Implications in inflammation, fibrosis, and proliferation. Cancer Lett (2013) 0.94
Isolation and identification of cell-specific microRNAs targeting a messenger RNA using a biotinylated anti-sense oligonucleotide capture affinity technique. Nucleic Acids Res (2013) 0.92
MicroRNA expressions associated with progression of prostate cancer cells to antiandrogen therapy resistance. Mol Cancer (2014) 0.90
Prenylated c17orf37 induces filopodia formation to promote cell migration and metastasis. J Biol Chem (2011) 0.90
The importance of alpha-1 antitrypsin (alpha1-AT) and neopterin serum levels in the evaluation of non-small cell lung and prostate cancer patients. Neuro Endocrinol Lett (2010) 0.88
MicroRNAs in normal and cancer cells: a new class of gene expression regulators. Exp Oncol (2006) 0.87
Solution structure of the oncogenic MIEN1 protein reveals a thioredoxin-like fold with a redox-active motif. PLoS One (2012) 0.77
Primary histologic diagnosis using automated whole slide imaging: a validation study. BMC Clin Pathol (2006) 3.51
Validating whole slide imaging for diagnostic purposes in pathology: guideline from the College of American Pathologists Pathology and Laboratory Quality Center. Arch Pathol Lab Med (2013) 3.39
Use of whole slide imaging in surgical pathology quality assurance: design and pilot validation studies. Hum Pathol (2006) 3.20
Xanthogranulomatous pyelonephritis. Arch Pathol Lab Med (2011) 2.01
An informatics model for tissue banks--lessons learned from the Cooperative Prostate Cancer Tissue Resource. BMC Cancer (2006) 1.97
Perivascular epithelioid cell tumor. Arch Pathol Lab Med (2009) 1.90
The development and deployment of Common Data Elements for tissue banks for translational research in cancer - an emerging standard based approach for the Mesothelioma Virtual Tissue Bank. BMC Cancer (2008) 1.88
A novel cross-disciplinary multi-institute approach to translational cancer research: lessons learned from Pennsylvania Cancer Alliance Bioinformatics Consortium (PCABC). Cancer Inform (2007) 1.76
Evaluation of whole slide image immunohistochemistry interpretation in challenging prostate needle biopsies. Hum Pathol (2008) 1.72
Lipomatous hypertrophy of the interatrial septum: an overview. Arch Pathol Lab Med (2006) 1.57
Developmental validation of a single-tube amplification of the 13 CODIS STR loci, D2S1338, D19S433, and amelogenin: the AmpFlSTR Identifiler PCR Amplification Kit. J Forensic Sci (2004) 1.51
A novel case of concurrent renal tumors: chromophobe renal cell carcinoma and carcinoid tumor of the kidney with brief review of renal neuroendocrine tumors. Int J Surg Pathol (2012) 1.50
The development and testing of a laboratory information system-driven tool for pre-sign-out quality assurance of random surgical pathology reports. Am J Clin Pathol (2010) 1.50
Experience with multimodality telepathology at the University of Pittsburgh Medical Center. J Pathol Inform (2012) 1.49
Hepatocyte paraffin 1 immunoexpression in esophageal brush samples. Cancer (2005) 1.44
Clinical examination and validation of primary diagnosis in anatomic pathology using whole slide digital images. Arch Pathol Lab Med (2011) 1.44
Malignant perivascular epithelioid cell tumor (PEComa) of the uterus with late renal and pulmonary metastases: a case report with review of the literature. Diagn Pathol (2007) 1.40
Synchronous primary carcinoid tumor and primary adenocarcinoma arising within mature cystic teratoma of horseshoe kidney: a unique case report and review of the literature. Diagn Pathol (2009) 1.38
Xp11.2 translocation renal cell carcinoma. Arch Pathol Lab Med (2010) 1.36
Epithelioid sarcoma. Arch Pathol Lab Med (2009) 1.32
Residency training in pathology informatics: a virtual rotation solution. Am J Clin Pathol (2009) 1.23
Primary carcinoid tumor arising within mature teratoma of the kidney: report of a rare entity and review of the literature. Diagn Pathol (2007) 1.18
Digital imaging in cytopathology. Patholog Res Int (2011) 1.15
Estrogen receptor beta functions through nongenomic mechanisms in lung cancer cells. Mol Endocrinol (2008) 1.14
Availability and quality of paraffin blocks identified in pathology archives: a multi-institutional study by the Shared Pathology Informatics Network (SPIN). BMC Cancer (2007) 1.14
Primary renal carcinoid tumors: clinicopathologic features of 9 cases with emphasis on novel immunohistochemical findings. Hum Pathol (2011) 1.09
Chromosome 14q loss defines a molecular subtype of clear-cell renal cell carcinoma associated with poor prognosis. Mod Pathol (2011) 1.09
Adenocarcinoma of the urinary bladder. Arch Pathol Lab Med (2011) 1.06
Synoptic tool for reporting of hematological and lymphoid neoplasms based on World Health Organization classification and College of American Pathologists checklist. BMC Cancer (2007) 1.06
Digital whole slide imaging in cytology. Arch Pathol Lab Med (2014) 1.06
An informatics supported web-based data annotation and query tool to expedite translational research for head and neck malignancies. BMC Cancer (2009) 1.06
Development and use of a genitourinary pathology digital teaching set for trainee education. J Pathol Inform (2010) 1.06
Whole genome SNP arrays as a potential diagnostic tool for the detection of characteristic chromosomal aberrations in renal epithelial tumors. Mod Pathol (2008) 1.05
Angiomyolipoma with epithelial cysts (AMLEC): a rare but distinct variant of angiomyolipoma. Diagn Pathol (2007) 1.05
Nephrogenic adenoma. Pathol Res Pract (2010) 1.04
Primary angiosarcoma of the testis: report of a rare entity and review of the literature. Diagn Pathol (2007) 1.04
Xp11.2 translocation renal cell carcinoma occurring during pregnancy with a novel translocation involving chromosome 19: a case report with review of the literature. Diagn Pathol (2009) 1.03
Challenges and opportunities in the adoption of College of American Pathologists checklists in electronic format: perspectives and experience of Reporting Pathology Protocols Project (RPP2) participant laboratories. Arch Pathol Lab Med (2010) 1.02
Increased cancer cell proliferation in prostate cancer patients with high levels of serum folate. Prostate (2011) 1.00
Tumor-to-tumor metastasis: case report of a pulmonary adenocarcinoma metastatic to a clear cell renal cell carcinoma. Pathol Res Pract (2011) 1.00
Cytologic evaluation of image-guided fine needle aspiration biopsies via robotic microscopy: A validation study. J Pathol Inform (2010) 0.99
Utility of a dual immunostain cocktail comprising of p53 and CK20 to aid in the diagnosis of non-neoplastic and neoplastic bladder biopsies. Diagn Pathol (2009) 0.99
Chondromyxoid fibroma of rib with a novel chromosomal translocation: a report of four additional cases at unusual sites. Diagn Pathol (2007) 0.99
Mixed epithelial and stromal tumors of the kidney: an overview. Arch Pathol Lab Med (2009) 0.99
Nuclear vitamin D receptor expression is associated with improved survival in non-small cell lung cancer. J Steroid Biochem Mol Biol (2010) 0.99
Primary bladder adenocarcinoma versus metastatic colorectal adenocarcinoma: a persisting diagnostic challenge. Diagn Pathol (2012) 0.99
Cardiac sarcoidosis: a pathology-focused review. Arch Pathol Lab Med (2010) 0.98
Conditional expression of human 15-lipoxygenase-1 in mouse prostate induces prostatic intraepithelial neoplasia: the FLiMP mouse model. Neoplasia (2006) 0.96
The history of pathology informatics: A global perspective. J Pathol Inform (2013) 0.96
Micropapillary urothelial carcinoma: clinico-pathologic review. Pathol Res Pract (2009) 0.95
Signal transducer and activator of transcription 6 (STAT6) is a novel interactor of annexin A2 in prostate cancer cells. Biochemistry (2010) 0.94
Idiopathic granulomatous orchitis. Pathol Res Pract (2011) 0.94
Use of contextual inquiry to understand anatomic pathology workflow: Implications for digital pathology adoption. J Pathol Inform (2012) 0.93
National Mesothelioma Virtual Bank: a standard based biospecimen and clinical data resource to enhance translational research. BMC Cancer (2008) 0.92
Renal cell carcinoma in a 33-year-old male with an unusual morphology and an aggressive clinical course: possible Xp11.2 translocation. Pathology (2008) 0.92
Use of immunohistochemical markers to confirm the presence of vas deferens in vasectomy specimens. Am J Clin Pathol (2009) 0.92
Diffuse expression of PAX2 and PAX8 in the cystic epithelium of mixed epithelial stromal tumor, angiomyolipoma with epithelial cysts, and primary renal synovial sarcoma: evidence supporting renal tubular differentiation. Am J Surg Pathol (2011) 0.92
Usefulness of a synoptic data tool for reporting of head and neck neoplasms based on the College of American Pathologists cancer checklists. Am J Clin Pathol (2009) 0.92
Spermatocytic seminoma. Arch Pathol Lab Med (2009) 0.91
A decade of experience in the development and implementation of tissue banking informatics tools for intra and inter-institutional translational research. J Pathol Inform (2010) 0.91
Mollaret's meningitis: cytopathologic analysis of fourteen cases. Diagn Cytopathol (2003) 0.90
Design and utilization of the colorectal and pancreatic neoplasm virtual biorepository: An early detection research network initiative. J Pathol Inform (2010) 0.90
p63 immunohistochemistry differentiates salivary gland oncocytoma and oncocytic carcinoma from metastatic renal cell carcinoma. Head Neck Pathol (2007) 0.90
Review of advanced imaging techniques. J Pathol Inform (2012) 0.90
Privacy and security of patient data in the pathology laboratory. J Pathol Inform (2013) 0.89
Initial experience with a novel pre-sign-out quality assurance tool for review of random surgical pathology diagnoses in a subspecialty-based university practice. Am J Surg Pathol (2010) 0.89
Heterotopic breast epithelial inclusion of the heart: report of a case. Am J Surg Pathol (2010) 0.88
Glomus tumor of renal pelvis: a case report and review of the literature. Hum Pathol (2005) 0.88
Cytomorphology of lymphoepithelioma-like carcinoma of the urinary bladder: report of two cases. Diagn Cytopathol (2008) 0.88
Immunohistochemical analysis of ezrin-radixin-moesin-binding phosphoprotein 50 in prostatic adenocarcinoma. BMC Urol (2011) 0.88
Diagnostic utility of p63/P501S double sequential immunohistochemical staining in differentiating urothelial carcinoma from prostate carcinoma. Diagn Pathol (2011) 0.87
Cytopathologic findings in breast masses in men with HIV infection. Acta Cytol (2003) 0.87
Integration of digital gross pathology images for enterprise-wide access. J Pathol Inform (2012) 0.86
Coactivator SRC-2-dependent metabolic reprogramming mediates prostate cancer survival and metastasis. J Clin Invest (2015) 0.86
Primitive neuroectodermal tumor arising in a testicular teratoma with retroperitoneal metastasis: report of an interesting case with review of literature. Urology (2007) 0.85
The importance of pathology informatics in translational research. Adv Anat Pathol (2007) 0.85
Diagnostic utility of p501s (prostein) in comparison to prostate specific antigen (PSA) for the detection of metastatic prostatic adenocarcinoma. Diagn Pathol (2007) 0.85
Translocator protein blockade reduces prostate tumor growth. Clin Cancer Res (2009) 0.85
p16ink4 immunoreactivity is a reliable marker for urothelial carcinoma in situ. Hum Pathol (2008) 0.84
Survival outcomes in endometrial cancer patients are associated with CXCL12 and estrogen receptor expression. Int J Cancer (2012) 0.84
Prostatic adenocarcinoma metastatic to pleomorphic liposarcoma, a "collision phenomenon": report of a case with review of pelvic collision tumors. Patholog Res Int (2011) 0.84
Contemporary issues in transfusion medicine informatics. J Pathol Inform (2011) 0.84
Lymphoepithelioma-like carcinoma of the urinary bladder. Pathology (2008) 0.83
Small glandular proliferations on needle biopsies: most common benign mimickers of prostatic adenocarcinoma sent in for expert second opinion. Am J Surg Pathol (2005) 0.83
Adenomatoid tumor of testis. Clin Med Pathol (2009) 0.82
CLT1 targets bladder cancer through integrin α5β1 and CLIC3. Mol Cancer Res (2012) 0.82
Renal oncocytoma: a comparative clinicopathologic study and fluorescent in-situ hybridization analysis of 73 cases with long-term follow-up. Diagn Pathol (2010) 0.82
Epidermal inclusion cyst presenting as a palpable scrotal mass. Case Rep Urol (2012) 0.81
Renal cell neoplasms contain shared tumor type-specific copy number variations. Am J Pathol (2012) 0.81
Central pathology review for phase III clinical trials: the enabling effect of virtual microscopy. Arch Pathol Lab Med (2013) 0.81
Deficiency of DNA repair nuclease ERCC1-XPF promotes prostate cancer progression in a tissue recombination model. Prostate (2011) 0.80
Relationship between magnification and resolution in digital pathology systems. J Pathol Inform (2013) 0.80
Development of a reactive stroma associated with prostatic intraepithelial neoplasia in EAF2 deficient mice. PLoS One (2013) 0.80
Effectiveness of random and focused review in detecting surgical pathology error. Am J Clin Pathol (2008) 0.80
Polyoma virus-associated cellular changes in the urine and bladder biopsy samples: a cytohistologic correlation. Am J Surg Pathol (2006) 0.80
Papillary renal cell carcinoma with low-grade spindle cell foci: a mimic of mucinous tubular and spindle cell carcinoma. Am J Surg Pathol (2008) 0.80
Fine needle aspiration biopsy of renal mucinous tubular and spindle cell carcinoma: report of two cases. Diagn Cytopathol (2010) 0.79
Orthotopic expression of human 15-lipoxygenase (LO)-1 in the dorsolateral prostate of normal wild-type C57BL/6 mouse causes PIN-like lesions. Prostaglandins Other Lipid Mediat (2006) 0.79
Sarcomatoid urothelial carcinoma with choriocarcinomatous features: first report of an unusual case. Urology (2007) 0.78
Pleomorphic leiomyosarcoma of the adrenal gland: case report and review of the literature. Urology (2007) 0.78